Dexrazoxane Intravenous and Histrelin Implant (Prostate Cancer)
Determining the interaction of Dexrazoxane Intravenous and Histrelin Implant (Prostate Cancer) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Histrelin Subcutaneous
- Dexrazoxane Intravenous-Histuss PD
- Dexrazoxane Intravenous-Hivid
- Dexrazoxane Intravenous-Hizentra
- Dexrazoxane Intravenous-HMS
- Dexrazoxane Intravenous-Hold
- Histrelin Implant (Prostate Cancer)-Dextenza Insert
- Histrelin Implant (Prostate Cancer)-Dextenza intraocular
- Histrelin Implant (Prostate Cancer)-Dextran 40
- Histrelin Implant (Prostate Cancer)-Dextran 70 6% in 5% Dextrose high molecular weight
- Histrelin Implant (Prostate Cancer)-Dextran 75
- Histrelin Implant (Prostate Cancer)-Dextran high molecular weight